Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Recent & Breaking News (NDAQ:DXR)

THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY

GlobeNewswire November 19, 2020

OREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100® STUDY

GlobeNewswire October 29, 2020

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl

GlobeNewswire October 12, 2020

The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020

Accesswire October 8, 2020

New Research Shows Daxor's BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020

GlobeNewswire October 6, 2020

New Research Demonstrates Daxor BVA-100® Blood Test Provides "Extremely Cost-Effective" Improvement in Patient Life Span at the Heart Failure Society of America Annual Scientific Meeting 2020

GlobeNewswire October 5, 2020

New Data Released from the Mayo Clinic Utilizing Daxor's BVA-100® Test Highlights Value of Daxor's Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020

GlobeNewswire October 2, 2020

Daxor Corporation to Exhibit and Showcase Compelling New Data at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020 on the Value of BVA-100®

GlobeNewswire September 28, 2020

Daxor to Present at the Inaugural Sepsis Alliance Summit

GlobeNewswire September 15, 2020

Daxor to Present at H.C. Wainwright 22nd Annual Global Investment Conference

GlobeNewswire September 10, 2020

Daxor Corporation to Present at the LD 500 Virtual Investor Conference

GlobeNewswire August 31, 2020

Daxor Corporation reports a 29.6 Percent Rise in Sales Revenue for Six Months in Filing of Form N-CSR for June 30, 2020

GlobeNewswire August 24, 2020

DAXOR ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH THE UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES

GlobeNewswire August 4, 2020

Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering

GlobeNewswire July 20, 2020

DAXOR ANNOUNCES PROSPECTIVE RANDOMIZED CONTROL TRIAL AT DUKE UNIVERSITY MEDICAL CENTER TO GUIDE VOLUME TREATMENT IN HEART FAILURE PATIENTS

GlobeNewswire July 16, 2020

Daxor Announces Initiation of First-of-Its-Kind Multicenter BVA-100® Study in Hospitalized Patients With COVID-19

GlobeNewswire July 15, 2020

DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH AMERICAN MEDICAL DEPOT GOVERNMENT DISTRIBUTOR

GlobeNewswire July 8, 2020

Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company's Board of Directors

GlobeNewswire June 30, 2020

Daxor Corporation, CEO Michael Feldschuh to Participate in Maxim Group's COVID-19 Virtual Conference on May 27, 2020

GlobeNewswire May 26, 2020

Daxor's BVA-100® Published in Novel Study in American Heart Association Journal - Circulation

GlobeNewswire May 22, 2020